www.cytosorbents.com
Open in
urlscan Pro
2606:4700:10::6816:4185
Public Scan
Submitted URL: http://www.cytosorbents.com/
Effective URL: https://www.cytosorbents.com/
Submission: On July 12 via manual from US — Scanned from US
Effective URL: https://www.cytosorbents.com/
Submission: On July 12 via manual from US — Scanned from US
Form analysis 1 forms found in the DOM
Name: searchform — https://www.cytosorbents.com/
<form name="searchform" action="https://www.cytosorbents.com/" class="searchform" id="searchform">
<input class="search-field" name="s" type="text" placeholder="Search" value="">
<input class="search-submit" type="submit">
</form>Text Content
We value your privacy We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Customize Reject All Accept All Customize Consent Preferences We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below. The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... Show more NecessaryAlways Active Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data. No cookies to display. Functional Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features. No cookies to display. Analytics Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc. No cookies to display. Performance Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors. No cookies to display. Advertisement Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns. No cookies to display. Reject All Save My Preferences Accept All X U.S. FDA Grants CytoSorb® Emergency Use Authorization for Use in Patients with COVID-19 Infection. Call 848-667-8990 to Order. ≡ * About * Products * Technology * Investor Relations * News * Contact ‹ › * slider1.jpg * slider1.jpg * slider1.jpg * slider1.jpg * slider1.jpg * slider1.jpg * slider1.jpg * slider1.jpg WORKING TO SAVE LIVES CytoSorb® is a unique blood purification therapy to control deadly inflammation in life-threatening illnesses in the ICU and cardiac surgery. The product is currently approved in the European Union and distributed in 75 countries around the world. THE POWER OF THE BEAD Powered by massive surface area, our purification technologies are based on biocompatible, highly porous polymer beads that can actively remove excessive cytokines and other inflammatory mediators from blood and other bodily fluids by pore capture and surface adsorption. INFORMATION FOR INVESTORS CytoSorbents specializes in treating life-threatening conditions in the ICU and during open heart surgery. The company is committed to serving the best interests of our patients and their families, our customers, our employees, and our shareholders. RECENT NEWS * CytoSorbents Secures $20 Million Credit Facility Source: Globenewswire July 2, 2024 * CytoSorbents 公司宣布 CytoSorb® 獲得台灣監管部門批准 Source: Globenewswire June 25, 2024 * CytoSorbents Announces Regulatory Approval of CytoSorb® in Taiwan Source: Globenewswire June 24, 2024 * CytoSorbents Announces the Launch and Immediate Availability of the PuriFi™ Blood Pump in the European Union Source: Globenewswire June 13, 2024 * CytoSorbents to Host its 2024 Virtual Annual Stockholders Meeting Source: Globenewswire June 5, 2024 * Coronavirus treatment developer hopes FDA will fast-track the therapy in US * Q&A: Blood purification can effectively treat COVID-19 patients Special * CytoSorbents Completes U.S. and Canadian STAR-T Pivotal Trial Video Player is loading. Play Video Play Mute Current Time 0:00 / Duration 3:37 Loaded: 1.11% 0:00 Stream Type LIVE Seek to live, currently behind liveLIVE Remaining Time -3:37 1x Playback Rate Chapters * Chapters Descriptions * descriptions off, selected Captions * captions settings, opens captions settings dialog * captions off, selected Audio Track Picture-in-PictureFullscreen This is a modal window. Beginning of dialog window. Escape will cancel and close the window. TextColorWhiteBlackRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-TransparentBackgroundColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-TransparentTransparentWindowColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyTransparentSemi-TransparentOpaque Font Size50%75%100%125%150%175%200%300%400%Text Edge StyleNoneRaisedDepressedUniformDropshadowFont FamilyProportional Sans-SerifMonospace Sans-SerifProportional SerifMonospace SerifCasualScriptSmall Caps Reset restore all settings to the default valuesDone Close Modal Dialog End of dialog window. Video Player is loading. Play Video Play Mute Current Time 0:00 / Duration 2:23 Loaded: 1.68% 0:00 Stream Type LIVE Seek to live, currently behind liveLIVE Remaining Time -2:23 1x Playback Rate Chapters * Chapters Descriptions * descriptions off, selected Captions * captions settings, opens captions settings dialog * captions off, selected Audio Track Picture-in-PictureFullscreen This is a modal window. Beginning of dialog window. Escape will cancel and close the window. TextColorWhiteBlackRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-TransparentBackgroundColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-TransparentTransparentWindowColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyTransparentSemi-TransparentOpaque Font Size50%75%100%125%150%175%200%300%400%Text Edge StyleNoneRaisedDepressedUniformDropshadowFont FamilyProportional Sans-SerifMonospace Sans-SerifProportional SerifMonospace SerifCasualScriptSmall Caps Reset restore all settings to the default valuesDone Close Modal Dialog End of dialog window. Video Player is loading. Play Video Play Mute Current Time 0:00 / Duration 3:55 Loaded: 0.96% 0:00 Stream Type LIVE Seek to live, currently behind liveLIVE Remaining Time -3:55 1x Playback Rate Chapters * Chapters Descriptions * descriptions off, selected Captions * captions settings, opens captions settings dialog * captions off, selected Audio Track Picture-in-PictureFullscreen This is a modal window. Beginning of dialog window. Escape will cancel and close the window. TextColorWhiteBlackRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-TransparentBackgroundColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-TransparentTransparentWindowColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyTransparentSemi-TransparentOpaque Font Size50%75%100%125%150%175%200%300%400%Text Edge StyleNoneRaisedDepressedUniformDropshadowFont FamilyProportional Sans-SerifMonospace Sans-SerifProportional SerifMonospace SerifCasualScriptSmall Caps Reset restore all settings to the default valuesDone Close Modal Dialog End of dialog window. <!– CEO OF CYTOSORBENTS PHILLIP CHAN DISCUSSES THE COMPANY’S EARNINGS REPORT –> * Privacy Information * Data protection * Disclaimer * contact CytoSorbents is a leader in critical care immunotherapy. The company is committed to serving the best interests of our patients and their families, our customers, our employees, and our shareholders. Are you an Investor? CytoSorb® is a unique blood purification therapy.The product is currently approved in the European Union and distributed in 58 countries around the world Are you a Healthcare Provider?